Determination of a vector of therapy for weakness in incurable breast cancer patients based on the level of inflammatory response
Vol. 62 No. 1 (2016), Articles
Vol. 62 No. 1 (2016)

Determination of a vector of therapy for weakness in incurable breast cancer patients based on the level of inflammatory response

Articles
https://doi.org/10.37469/0507-3758-2016-62-1-104-111
Published 15.12.2016
N.N.Petrov Research Institute of Oncology
N.N.Petrov Research Institute of Oncology
##article.numberofdownloads## 43
##article.numberofviews## 78
PDF (Русский)

Keywords

weakness
inflammation
incurability

How to Cite

, & . (2016). Determination of a vector of therapy for weakness in incurable breast cancer patients based on the level of inflammatory response. Voprosy Onkologii, 62(1), 104–111. https://doi.org/10.37469/0507-3758-2016-62-1-104-111
ACM ACS APA ABNT Chicago Harvard IEEE MLA Turabian Vancouver

Abstract

The weakness is one of the negative factors that degrade cancer patients’ quality of life. The nature of weakness may be multifactorial but among mechanisms of development of weakness a syndrome of chronic inflammation plays a crucial role. Therapy aimed at reducing of inflammation degree allows correcting other cancer-related symptoms and improving the quality of life of incurable patients.
https://doi.org/10.37469/0507-3758-2016-62-1-104-111
##article.numberofdownloads## 43
##article.numberofviews## 78
PDF (Русский)

References

Бит-Сава Е.М. Генетические аспекты хирургического лечения больных с наследственным раком молочной железы // Вестн. хирургии им. И.И. Грекова. - 2014. - N 5. - С. 27-30.

Гусев Е.Ю., Юрченко Л.Н., Черешнев В.А. и др. Хроническое системное воспаление как типовой патологический процесс // Цитокины и воспаление. - 2008. - Т. 7. - № 4. - С. 3-10.

Зайнуллина Д.р Качество жизни пациентов с раком молочной железы после кожасохранных мастэктомий в сочетании с одномоментной реконструкцией молочной железы // Сиб. онкол. - 2015. - Приложение № 1. - Актуальные вопросы экспериментальной и клинической онкологии. - С. 35

Исакова М.Е. Алгоритм лечения онкологической боли // русск. мед. журнал (РМЖ) - 2007. -Т. 15. - № 6 (287). - C. 481 - 485.

Мерабишвили В.М. Эпидемиология и выживаемость больных раком молочной железы // Вопр. онкол. -2013. -Т. 59. - N 3. - С. 314-319.

рязанкина А.А., розенгард С.А., Глущенко В.А. и др. оптимизация фармакологической терапии синдрома слабости у инкурабельных пациентов // Вопр. онкол. - 2015. - Т. 61. - № 2. - С. 270-273.

Семиглазова Т.Ю. Новый подход к преодолению резистентности к гормонотерапии рака молочной железы // Фарматека. - 2012. - N 18. - С. 50-55.

Andrykowski MA, Curran SL, Lightner R. Off-treatment fatigue in breast cancer survivors: a controlled comparison // J Behav Med. - 1998. - Vol. 21 (1). - P. 1-18.

Fagundes C.P, Bennett J.M., Derry H.M., Kiecolt-Glaser J.K. Relationships and Inflammation across the Lifespan: Social Developmental Pathways to Disease // Soc Personal Psychol Compass. - 2011. - Vol. 5 (11). - P. 891903.

Goedendorp M.M., Andrykowski M.A., Donovan K.A. et al. Prolonged impact of chemotherapy on fatigue in breast cancer survivors: a longitudinal comparison with radiotherapy-treated breast cancer survivors and noncancer controls // Cancer. - 2012. - Vol. 1. - 118 (15). - P. 3833-3841.

Kilgour R.D. Cancer-related fatigue: the impact of skeletal muscle mass and strength in patients with advanced cancer // J Cachexia Sarcopenia Muscle. - 2010. - Vol.1 (2). - P 177-185.

Lawrence DP, Kupelnick B, Miller K. et al. Evidence report on the occurrence, assessment, and treatment of fatigue in cancer patients // J Natl Cancer Inst Monogr. - 2004. - Vol. 32. - P 40-50.

Mitchell S.A. Cancer-related fatigue: state of the science // Physical Medicine and Rehabilitation. - 2010. - Vol. 2 (5). - P. 364-383.

Montazeri A., Quality of life in patients with breast cancer before and after diagnosis: an eighteen months follow-up study // BMC. - Cancer. - 2008. - Vol. 8. -P. 330.

van Weert E., May A.M., Korstjens I. et al. Cancer-related fatigue: predictors and effects of rehabilitation // Oncologist. - 2006. - Vol. 11 (2). -P. 184-196.

Yavuzsen T. Davis MP. Ranganathan VK. et al. Cancer-related fatigue: Central or peripheral? // J Pain Symptom Manage. - 2009. - Vol. 38. - P. 587-596.

All the Copyright statements for authors are present in the standart Publishing Agreement (Public Offer) to Publish an Article in an Academic Periodical 'Problems in oncology' ...